Keyphrases
Autoimmune Hepatitis
100%
Primary Sclerosing Cholangitis
72%
Cirrhosis
51%
Primary Biliary Cholangitis
42%
Mannose-binding Lectin
40%
Colorectal Cancer
34%
Inflammatory Bowel Disease
33%
Autoimmune Liver Disease
30%
Liver Cirrhosis
25%
Europe
24%
Mannan-binding Lectin-associated Serine Proteases
23%
Acute Liver Failure
23%
European Reference Networks
22%
Mycophenolate Mofetil
21%
MBL-associated Serine Proteases
21%
Tacrolimus
20%
Second-line Therapy
20%
Diabetes
20%
Physical Exercise
20%
International Autoimmune Hepatitis Group (IAIHG)
20%
Biological Variation
20%
Circulating Levels
20%
Prognostic Value
20%
Lectin Pathway
20%
Health-related Quality of Life
20%
Ursodeoxycholic Acid
18%
Confidence Interval
18%
Serum Levels
15%
Liver
14%
Circadian Variation
14%
Glucose Disturbances
14%
Portal Hypertension
13%
Inflammation
13%
Response Criteria
13%
Alkaline Phosphatase
11%
Disease Course
11%
Etiology
11%
Liver Transplantation
11%
International Cohort
11%
Scoring System
11%
Denmark
11%
Hazard Ratio
10%
Diabetes Risk
10%
Lectin Protein
10%
Plasma Exchange
10%
Genotype
10%
MFAP4
10%
Induced Variation
10%
Proportional Meta-analysis
10%
Vascular Endothelial Growth Factor Receptor (VEGFR)
10%
Medicine and Dentistry
Primary Sclerosing Cholangitis
61%
Liver Cirrhosis
54%
Autoimmune Hepatitis
49%
Primary Biliary Cirrhosis
46%
Autoimmune Liver Disease
30%
Cohort Analysis
30%
Acute Liver Failure
25%
Inflammatory Bowel Disease
23%
Diabetes
23%
Scoring System
20%
Mannan Binding Lectin
20%
Ursodeoxycholic Acid
18%
Liver Disease
16%
Receptor
15%
Disease Course
14%
Combination Therapy
14%
Diagnosis
13%
Portal Hypertension
13%
Colorectal Cancer
12%
Systematic Review
11%
Cross Sectional Study
11%
Bile Acid
11%
Hazard Ratio
10%
Pediatrics
10%
Magnetic Resonance Imaging
10%
Meta-Analysis
10%
Rifaximin
10%
Alcohol Liver Disease
10%
Magnetic Resonance Cholangiopancreatography
10%
Plasma Exchange
10%
Hepatitis A
10%
Regulatory T Cell
10%
Penicillamine
10%
COVID-19
10%
Patient Referral
10%
Immunocompetent Cell
10%
Toxic Hepatitis
10%
Salvage Therapy
10%
B Cell
10%
Quality of Life
10%
T Cell
10%
Randomized Clinical Trial
10%
Wilson's Disease
10%
Major Surgery
10%
Innate Immunity
10%
Elective Surgery
10%
Vedolizumab
10%
Bile Acid Conjugate
10%
Transplantation
10%
Sphingolipid
10%
Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Hepatitis
63%
Liver Cirrhosis
47%
Primary Biliary Cirrhosis
32%
Disease
26%
Mycophenolic Acid
21%
Tacrolimus
20%
Autoimmune Liver Disease
20%
Hepatitis A
20%
Primary Sclerosing Cholangitis
18%
Acute Liver Failure
15%
Portal Hypertension
12%
Inflammation
11%
Symptom
11%
Tumor Necrosis Factor
11%
Biological Marker
11%
Remission
10%
Side Effect
10%
Randomized Clinical Trial
10%
Rifaximin
10%
Alcohol Liver Disease
10%
Toxic Hepatitis
10%
Cohort Study
10%
Vasculotropin Receptor 1
10%
Everolimus
10%
Bile Acid
10%
Cross-Sectional Study
10%
Inflammatory Bowel Disease
10%
Colorectal Cancer
10%
Coronavirinae
10%
Biological Variation
10%
Anti-Inflammatory Drug
10%
Surfactant Protein D
10%
Azathioprine
8%
Chronic Liver Disease
8%
Combination Therapy
8%
Bile Acid Conjugate
8%
Bleeding
8%
Non Insulin Dependent Diabetes Mellitus
7%
Insulin Dependent Diabetes Mellitus
7%
Alkaline Phosphatase
7%
Prevalence
6%
Vasculotropin
6%
Alanine Aminotransferase
5%
Obeticholic Acid
5%
Ursodeoxycholic Acid
5%
Receptor Agonist
5%
Infection
5%
